Volkow, N.D., Fowler, J.S., Wang, G.J., Baler, R. & Telang, F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56 (suppl. 1), 3–8 (2009).
Koob, G.F. & Le Moal, M. Addiction and the brain antireward system. Annu. Rev. Psychol. 59, 29–53 (2008).
Koob, G.F. & Bloom, F.E. Cellular and molecular mechanisms of drug dependence. Science 242, 715–723 (1988).
Koob, G.F. & Volkow, N.D. Neurocircuitry of addiction. Neuropsychopharmacology 35, 217–238 (2010).
Sarnyai, Z., Shaham, Y. & Heinrichs, S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 53, 209–243 (2001).
Picciotto, M.R. & Kenny, P.J. Molecular mechanisms underlying behaviors related to nicotine addiction. Cold Spring Harb. Perspect. Med. 3, a012112 (2013).
Boyson, C.O., Miguel, T.T., Quadros, I.M., Debold, J.F. & Miczek, K.A. Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA. Psychopharmacology (Berl.) 218, 257–269 (2011).
Hahn, J., Hopf, F.W. & Bonci, A. Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons. J. Neurosci. 29, 6535–6544 (2009).
Wanat, M.J., Bonci, A. & Phillips, P.E. CRF acts in the midbrain to attenuate accumbens dopamine release to rewards but not their predictors. Nat. Neurosci. 16, 383–385 (2013).
Wang, B., You, Z.B., Rice, K.C. & Wise, R.A. Stress-induced relapse to cocaine seeking: roles for the CRF2 receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology (Berl.) 193, 283–294 (2007).
Wang, H.L. & Morales, M. Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons. J. Comp. Neurol. 509, 302–318 (2008).
Blacktop, J.M. et al. Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2. J. Neurosci. 31, 11396–11403 (2011).
Vranjkovic, O., Gasser, P.J., Gerndt, C.H., Baker, D.A. & Mantsch, J.R. Stress-induced cocaine seeking requires a beta-2 adrenergic receptor-regulated pathway from the ventral bed nucleus of the stria terminalis that regulates CRF actions in the ventral tegmental area. J. Neurosci. 34, 12504–12514 (2014).
Grieder, T.E. et al. Dopaminergic signaling mediates the motivational response underlying the opponent motivational process to chronic but not acute nicotine. Neuropsychopharmacology 35, 943–954 (2010).
Grieder, T.E. et al. Phasic D1 and tonic D2 dopamine receptor signaling double dissociate the motivational effects of acute nicotine and chronic nicotine withdrawal. Proc. Natl. Acad. Sci. USA 109, 3101–3106 (2012).
Swanson, L.W., Sawchenko, P.E., Rivier, J. & Vale, W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36, 165–186 (1983).
Tagliaferro, P. & Morales, M. Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic. J. Comp. Neurol. 506, 616–626 (2008).
Kozicz, T. et al. The Edinger-Westphal nucleus: a historical, structural, and functional perspective on a dichotomous terminology. J. Comp. Neurol. 519, 1413–1434 (2011).
Zhao-Shea, R. et al. Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area. Neuropsychopharmacology 36, 1021–1032 (2011).
Merlo Pich, E. et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15, 5439–5447 (1995).
Funk, C.K., O'Dell, L.E., Crawford, E.F. & Koob, G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 26, 11324–11332 (2006).
Tolu, S. et al. Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement. Mol. Psychiatry 18, 382–393 (2013).
Hnasko, T.S., Hjelmstad, G.O., Fields, H.L. & Edwards, R.H. Ventral tegmental area glutamate neurons: electrophysiological properties and projections. J. Neurosci. 32, 15076–15085 (2012).
Nimitvilai, S., Arora, D.S., McElvain, M.A. & Brodie, M.S. Reversal of inhibition of putative dopaminergic neurons of the ventral tegmental area: interaction of GABA(B) and D2 receptors. Neuroscience 226, 29–39 (2012).
Doyon, W.M. et al. Nicotine decreases ethanol-induced dopamine signaling and increases self-administration via stress hormones. Neuron 79, 530–540 (2013).
Mansvelder, H.D., Keath, J.R. & McGehee, D.S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33, 905–919 (2002).
George, O. et al. CRF–CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc. Natl. Acad. Sci. USA 104, 17198–17203 (2007).
Cohen, A. et al. Extended access to nicotine leads to a CRF1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats. Addict. Biol. 10.1111/adb.12077 (2013).
Cohen, A., Koob, G.F. & George, O. Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence. Neuropsychopharmacology 37, 2153–2160 (2012).
Ludwig, M. & Leng, G. Dendritic peptide release and peptide-dependent behaviours. Nat. Rev. Neurosci. 7, 126–136 (2006).
Son, S.J. et al. Dendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks. Neuron 78, 1036–1049 (2013).
Treweek, J.B., Jaferi, A., Colago, E.E., Zhou, P. & Pickel, V.M. Electron microscopic localization of corticotropin-releasing factor (CRF) and CRF receptor in rat and mouse central nucleus of the amygdala. J. Comp. Neurol. 512, 323–335 (2009).
Wang, B. et al. Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J. Neurosci. 25, 5389–5396 (2005).
Marcinkiewcz, C.A. et al. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Neuropsychopharmacology 34, 1743–1752 (2009).
Baiamonte, B.A. et al. Nicotine dependence produces hyperalgesia: role of corticotropin-releasing factor-1 receptors (CRF1Rs) in the central amygdala (CeA). Neuropharmacology 77, 217–223 (2014).
Torres, O.V., Gentil, L.G., Natividad, L.A., Carcoba, L.M. & O'Dell, L.E. Behavioral, biochemical, and molecular indices of stress are enhanced in female versus male rats experiencing nicotine withdrawal. Front. Psychiatry 4, 38 (2013).
Zhang, L., Dong, Y., Doyon, W.M. & Dani, J.A. Withdrawal from chronic nicotine exposure alters dopamine signaling dynamics in the nucleus accumbens. Biol. Psychiatry 71, 184–191 (2012).
Lodge, D.J. & Grace, A.A. Acute and chronic corticotropin-releasing factor 1 receptor blockade inhibits cocaine-induced dopamine release: correlation with dopamine neuron activity. J. Pharmacol. Exp. Ther. 314, 201–206 (2005).
Willuhn, I., Burgeno, L.M., Groblewski, P.A. & Phillips, P.E. Excessive cocaine use results from decreased phasic dopamine signaling in the striatum. Nat. Neurosci. 17, 704–709 (2014).
Kalivas, P.W., Duffy, P. & Latimer, L.G. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J. Pharmacol. Exp. Ther. 242, 757–763 (1987).
van Zessen, R., Phillips, J.L., Budygin, E.A. & Stuber, G.D. Activation of VTA GABA neurons disrupts reward consumption. Neuron 73, 1184–1194 (2012).
Tan, K.R. et al. GABA neurons of the VTA drive conditioned place aversion. Neuron 73, 1173–1183 (2012).
Roberto, M. et al. Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biol. Psychiatry 67, 831–839 (2010).
Nader, K. & van der Kooy, D. Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area. J. Neurosci. 17, 383–390 (1997).
Vargas-Perez, H. et al. Ventral tegmental area BDNF induces an opiate-dependent like reward state in naive rats. Science 324, 1732–1734 (2009).
Laviolette, S.R., Alexson, T.O. & van der Kooy, D. Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area. J. Neurosci. 22, 8653–8660 (2002).
Steffensen, S.C. et al. Contingent and non-contingent effects of heroin on mu-opioid receptor-containing ventral tegmental area GABA neurons. Exp. Neurol. 202, 139–151 (2006).
Volkow, N.D., Fowler, J.S., Wang, G.J., Swanson, J.M. & Telang, F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch. Neurol. 64, 1575–1579 (2007).
Koob, G.F. et al. Addiction as a stress surfeit disorder. Neuropharmacology 76 (pt. B), 370–382 (2014).
Paxinos, G. & Franklin, K.B.J. The Mouse Brain in Stereotaxic Coordinates (Academic, San Diego, 1997).
Richardson, H.N. et al. MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol. Biochem. Behav. 88, 497–510 (2008).
Darcq, E. et al. RSK2 signaling in brain habenula contributes to place aversion learning. Learn. Mem. 18, 574–578 (2011).
Zolotukhin, S. et al. Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28, 158–167 (2002).